Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells

Youde Jiang, Jena J SteinleDepartment of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI, USAPurpose: Inflammation has been strongly associated with retinal damage in diseases such as diabetic retinopathy. Several studies have reported that high...

Full description

Bibliographic Details
Main Authors: Jiang Y, Steinle JJ
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Journal of Inflammation Research
Subjects:
PKR
Online Access:https://www.dovepress.com/epac1-inhibits-pkr-to-reduce-nlrp3-inflammasome-proteins-in-retinal-en-peer-reviewed-article-JIR
id doaj-de5c849afd984451972265bd3eae937e
record_format Article
spelling doaj-de5c849afd984451972265bd3eae937e2020-11-25T00:47:19ZengDove Medical PressJournal of Inflammation Research1178-70312019-06-01Volume 1215315946427Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cellsJiang YSteinle JJYoude Jiang, Jena J SteinleDepartment of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI, USAPurpose: Inflammation has been strongly associated with retinal damage in diseases such as diabetic retinopathy. Several studies have reported that high glucose exposure induces damage to the retinal vasculature. We and others have shown that high glucose can activate the NOD-like receptor family, pyrin domain containing family member 3 (NLRP3) pathway, leading to increased levels of cleaved caspase 1 and IL-1β to activate a number of inflammatory pathways in the retina.Methods: We used retinal endothelial cells grown in normal (5 mM) or high (25 mM) glucose or retinal lysates from endothelial cell-specific knockout mice for exchange protein activated by cAMP 1 (Epac1). Human recombinant protein kinase R (PKR) or C16, a PKR inhibitor, was used on the cells to dissect PKR and NLRP3 signaling.Results: Using retinal endothelial cells (REC) in high glucose and whole retinal lysates from endothelial cell-specific knockout of Epac1, we demonstrate that Epac1 regulates PKR phosphorylation. Using an Epac1 agonist or PKR inhibition with C16, we demonstrated that loss of PKR resulted in reduced NLRP3, cleaved caspase 1, and IL-1β levels. Furthermore, despite the addition of recombinant human PKR, Epac1 was still able to significantly reduce NLRP3 signaling.Conclusion: Overall, these studies demonstrated that PKR regulates the NLRP3 inflammasome in REC, and that Epac1 inhibition of PKR can reduce activation of the NLRP3 inflammasome.Keywords: inflammasome, NLRP3, PKR, retinal endothelial cellshttps://www.dovepress.com/epac1-inhibits-pkr-to-reduce-nlrp3-inflammasome-proteins-in-retinal-en-peer-reviewed-article-JIRinflammasomeNLRP3PKRretinal endothelial cells
collection DOAJ
language English
format Article
sources DOAJ
author Jiang Y
Steinle JJ
spellingShingle Jiang Y
Steinle JJ
Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
Journal of Inflammation Research
inflammasome
NLRP3
PKR
retinal endothelial cells
author_facet Jiang Y
Steinle JJ
author_sort Jiang Y
title Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_short Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_full Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_fullStr Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_full_unstemmed Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_sort epac1 inhibits pkr to reduce nlrp3 inflammasome proteins in retinal endothelial cells
publisher Dove Medical Press
series Journal of Inflammation Research
issn 1178-7031
publishDate 2019-06-01
description Youde Jiang, Jena J SteinleDepartment of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI, USAPurpose: Inflammation has been strongly associated with retinal damage in diseases such as diabetic retinopathy. Several studies have reported that high glucose exposure induces damage to the retinal vasculature. We and others have shown that high glucose can activate the NOD-like receptor family, pyrin domain containing family member 3 (NLRP3) pathway, leading to increased levels of cleaved caspase 1 and IL-1β to activate a number of inflammatory pathways in the retina.Methods: We used retinal endothelial cells grown in normal (5 mM) or high (25 mM) glucose or retinal lysates from endothelial cell-specific knockout mice for exchange protein activated by cAMP 1 (Epac1). Human recombinant protein kinase R (PKR) or C16, a PKR inhibitor, was used on the cells to dissect PKR and NLRP3 signaling.Results: Using retinal endothelial cells (REC) in high glucose and whole retinal lysates from endothelial cell-specific knockout of Epac1, we demonstrate that Epac1 regulates PKR phosphorylation. Using an Epac1 agonist or PKR inhibition with C16, we demonstrated that loss of PKR resulted in reduced NLRP3, cleaved caspase 1, and IL-1β levels. Furthermore, despite the addition of recombinant human PKR, Epac1 was still able to significantly reduce NLRP3 signaling.Conclusion: Overall, these studies demonstrated that PKR regulates the NLRP3 inflammasome in REC, and that Epac1 inhibition of PKR can reduce activation of the NLRP3 inflammasome.Keywords: inflammasome, NLRP3, PKR, retinal endothelial cells
topic inflammasome
NLRP3
PKR
retinal endothelial cells
url https://www.dovepress.com/epac1-inhibits-pkr-to-reduce-nlrp3-inflammasome-proteins-in-retinal-en-peer-reviewed-article-JIR
work_keys_str_mv AT jiangy epac1inhibitspkrtoreducenlrp3inflammasomeproteinsinretinalendothelialcells
AT steinlejj epac1inhibitspkrtoreducenlrp3inflammasomeproteinsinretinalendothelialcells
_version_ 1725260659948519424